This proposal is based on the belief that defects in insulin-mediated glucose disposal are closely related to abnormalities of insulin regulation of adipose tissue within an individual, and that these changes will have untoward consequences. The investigators plan to test the following four hypotheses: 1) non-diabetics who are resistant to insulin-mediated glucose disposal by muscle have a parallel defect in the ability of insulin to suppress adipose tissue lipolysis as assessed by free fatty acid turnover; 2) muscle insulin resistance in non-diabetic individuals is not secondary to enhanced tissue lipolysis and increased FFA concentrations, but is a manifestation of a more fundamental defect in insulin signaling; 3) glucose-induced pancreatic b-cell insulin secretion will be attenuated in non-diabetic subjects who have a defect in the ability of insulin to regulate adipose tissue lipolysis, and 4) abnormalities in the lipolytic response of adipose tissue and in pancreatic b-cell function associated with resistance to insulin-mediated glucose disposal in non-diabetic subjects will also be evident in non-diabetic first degree relatives of insulin resistant as compared to insulin sensitive individuals. To address these issues, 320 healthy, non-obese, non-diabetic volunteers will be recruited for a cross-sectional study in which they will quantify age, BMI, waist to hip ratio, insulin resistance, FFA turnover at basal and isoproterenol and with insulin suppression of isoproterenol lipolysis, and ad insulin secretion. They will additionally recruit 100 healthy nonobese nondiabetic first degree relatives of the probands; 50 from the highest and 50 from the lowest quartiles of insulin sensitivities. All measurements will be done on the relatives, also. Finally, measurements will be repeated in the 80 most insulin resistant probands after an increase in carbohydrate intake for 7 days. The results of the study should provide information to which defects in insulin mediated glucose disposal, lipolysis and insulin secretion occur together, the link between abnormalities, and role of familiarity.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK030732-13
Application #
2684118
Study Section
Metabolism Study Section (MET)
Program Officer
Laughlin, Maren R
Project Start
1983-01-01
Project End
2001-03-31
Budget Start
1998-04-01
Budget End
1999-03-31
Support Year
13
Fiscal Year
1998
Total Cost
Indirect Cost
Name
Stanford University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
800771545
City
Stanford
State
CA
Country
United States
Zip Code
94305
Abbasi, Fahim; Chu, James W; McLaughlin, Tracey et al. (2004) Effect of metformin treatment on multiple cardiovascular disease risk factors in patients with type 2 diabetes mellitus. Metabolism 53:159-64
Chu, James W; Abbasi, Fahim; Beatty, George W et al. (2003) Methods for quantifying insulin resistance in human immunodeficiency virus-positive patients. Metabolism 52:858-61
McLaughlin, T; Abbasi, F; Lamendola, C et al. (2001) Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity. Metabolism 50:819-24
Santos, R F; Nomizo, R; Oliveira, E et al. (2000) Erythrocyte insulin receptor tyrosine kinase activity is increased in glyburide-treated patients with type 2 diabetes in good glycaemic control. Diabetes Obes Metab 2:237-41
Abbasi, F; McLaughlin, T; Lamendola, C et al. (2000) The relationship between glucose disposal in response to physiological hyperinsulinemia and basal glucose and free fatty acid concentrations in healthy volunteers. J Clin Endocrinol Metab 85:1251-4
Rosolova, H; Mayer Jr, O; Reaven, G M (2000) Insulin-mediated glucose disposal is decreased in normal subjects with relatively low plasma magnesium concentrations. Metabolism 49:418-20
Abbasi, F; McLaughlin, T; Lamendola, C et al. (2000) Insulin regulation of plasma free fatty acid concentrations is abnormal in healthy subjects with muscle insulin resistance. Metabolism 49:151-4
Chen, N G; Reaven, G M (1999) Fatty acid inhibition of glucose-stimulated insulin secretion is enhanced in pancreatic islets from insulin-resistant rats. Metabolism 48:1314-7
Abbasi, F; Carantoni, M; Chen, Y D et al. (1998) Further evidence for a central role of adipose tissue in the antihyperglycemic effect of metformin. Diabetes Care 21:1301-5
Maheux, P; Chen, Y D; Polonsky, K S et al. (1997) Evidence that insulin can directly inhibit hepatic glucose production. Diabetologia 40:1300-6

Showing the most recent 10 out of 46 publications